Marina del Bue
Corporate Officer/Principal chez Federazione Nazionale dell'Industria Chimica
Profil
Ms. Marina del Bue is Executive Director & GM-Administration at Molecular Medicine SpA and Council Member at Federazione Nazionale dell'Industria Chimica.
She is on the Board of Directors at Molecular Medicine SpA.
Ms. del Bue was previously employed as R&D Controller by A.
Menarini Industrie Farmaceutiche Riunite SRL.
She received her undergraduate degree from the Sapienza University of Rome and an MBA from the SDA Bocconi School of Management.
Postes actifs de Marina del Bue
| Sociétés | Poste | Début |
|---|---|---|
| Federazione Nazionale dell'Industria Chimica | Corporate Officer/Principal | - |
Anciens postes connus de Marina del Bue
| Sociétés | Poste | Fin |
|---|---|---|
| MOLMED S.P.A. | Directeur Administratif | 22/10/2015 |
A. Menarini Industrie Farmaceutiche Riunite SRL
 A. Menarini Industrie Farmaceutiche Riunite SRL Pharmaceuticals: MajorHealth Technology A. Menarini Industrie Farmaceutiche Riunite SRL operates as a pharmaceutical company. It specializes in the research, development, and marketing of products for therapy and wellness, diagnostics, and biotechnology. The company was founded in 1886 and is headquartered in Florence, Italy. | Comptroller/Controller/Auditor | - |
Formation de Marina del Bue
| Sapienza University of Rome | Undergraduate Degree |
| SDA Bocconi School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
AGC Biologics SpA
 AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
A. Menarini Industrie Farmaceutiche Riunite SRL
A. Menarini Industrie Farmaceutiche Riunite SRL Pharmaceuticals: MajorHealth Technology A. Menarini Industrie Farmaceutiche Riunite SRL operates as a pharmaceutical company. It specializes in the research, development, and marketing of products for therapy and wellness, diagnostics, and biotechnology. The company was founded in 1886 and is headquartered in Florence, Italy. | Health Technology |
| Federazione Nazionale dell'Industria Chimica |
